|
||
Article |
Correspondence to Peter Mayinger: mayinger{at}ohsu.edu
When a growing cell expands, lipids and proteins must be delivered to its periphery. Although this phenomenon has been observed for decades, it remains unknown how the secretory pathway responds to growth signaling. We demonstrate that control of Golgi phosphatidylinositol-4-phosphate (PI(4)P) is required for growth-dependent secretion. The phosphoinositide phosphatase SAC1 accumulates at the Golgi in quiescent cells and down-regulates anterograde trafficking by depleting Golgi PI(4)P. Golgi localization requires oligomerization of SAC1 and recruitment of the coat protein (COP) II complex. When quiescent cells are stimulated by mitogens, SAC1 rapidly shuttles back to the endoplasmic reticulum (ER), thus releasing the brake on Golgi secretion. The p38 mitogen-activated kinase (MAPK) pathway induces dissociation of SAC1 oligomers after mitogen stimulation, which triggers COP-I–mediated retrieval of SAC1 to the ER. Inhibition of p38 MAPK abolishes growth factor–induced Golgi-to-ER shuttling of SAC1 and slows secretion. These results suggest direct roles for p38 MAPK and SAC1 in transmitting growth signals to the secretory machinery.
| Introduction |
|---|
|
|
|---|
Studies in yeast and mammals have shown that the transmembrane lipid phosphatase SAC1 is responsible for PI(4)P turnover at the ER and Golgi (Foti et al., 2001; Schorr et al., 2001; Rohde et al., 2003). Yeast Sac1p associates with the ER-specific enzyme dolicholphosphate-mannose synthase Dpm1p (Faulhammer et al., 2005). In contrast, ER localization of mammalian SAC1 is mediated by the canonical coatomer complex coat protein (COP) I binding motif missing in the yeast homologue (Rohde et al., 2003). It is unknown, however, how the distribution of SAC1 between the ER and Golgi is achieved. In addition, the cellular function of mammalian SAC1 at the Golgi has not been defined. Lipids and proteins must cooperate to regulate the transport and sorting functions performed by the Golgi. We hypothesized that PI levels at the Golgi may be regulated in a cell growth–dependent manner, thus coupling lipid signaling and anterograde traffic to cell proliferation. In this study, we analyzed the role of the lipid phosphatase SAC1 in mitogen-stimulated control of secretion.
| Results |
|---|
|
|
|---|
15 min (Fig. 1 D). The same redistribution of SAC1 occurred in cells treated with cycloheximide to block protein synthesis before serum stimulation, thus indicating that a preexisting pool of SAC1 translocated from the Golgi to the ER in a growth-dependent fashion (Fig. S1 A, available at http://www.jcb.org/cgi/content/full/jcb.20070109/DC1).
|
|
An N-terminal leucine zipper (LZ) motif in SAC1 is required for oligomerization
To identify the critical regions within SAC1 required for its translocation to the Golgi, we generated GFP-tagged SAC1 mutants. A truncated GFP-SAC1 that lacked the entire N-terminal cytosolic domain (GFP-SAC1
N) failed to accumulate at the Golgi upon serum starvation (Fig. S1 C), indicating that the N-terminal domain of SAC1 is necessary for SAC1 redistribution to the Golgi. Mammalian SAC1 homologues contain a potential LZ motif within their N-terminal cytosolic domain (Fig. 2 A). LZs form coiled-coil secondary structures implicated in assembly of protein oligomers (Lupas, 1996). To examine whether growth-dependent ER-to-Golgi shuttling of SAC1 is regulated by LZ-dependent oligomerization, we generated the mutant SAC1-LZ, in which this motif was mutated. Alanine substitutions of the four leucines within the LZ abolished the ability of flag-SAC1 to form oligomers, bind to the COP-II complex, or shuttle to the Golgi under any growth conditions (Fig. 2, D and E). Measurements of phosphatase activity of affinity-purified flag-SAC1-LZ showed that the catalytic activity was nearly identical to that determined for flag-SAC1 (Fig. 2 F). This result therefore precludes that oligomerization of SAC1 is a prerequisite for phosphatase activity.
Mitogen activation of quiescent cells triggers Golgi-to-ER translocation of SAC1
Because the intracellular distribution of SAC1 changed significantly in response to serum levels, we surmised that serum constituents might be involved in controlling SAC1 trafficking. Serum growth factors are among the most important stimuli that trigger cell growth and survival. We therefore tested individual growth factors for their ability to induce SAC1 shuttling from the Golgi to the ER in quiescent NIH3T3 cells. Stimulation of quiescent cells with a combination of PDGF, FGF, and EGF caused the same prompt translocation of SAC1 to the ER as was observed after stimulation with serum (Fig. 3 A).
When we analyzed individual growth factors for their ability to stimulate SAC1 redistribution from the Golgi to the ER in quiescent cells, we found that FGF and PDGF were equally potent in promoting SAC1 shuttling, whereas EGF was less effective (Fig. 3 B). This finding suggests that Golgi-to-ER shuttling of SAC1 is controlled by growth factor signaling.
|
Activation of the p38 MAPK pathway triggers dissociation of SAC1 oligomers and is required for mitogen-induced constitutive secretion
Our results show that p38 MAPK activity is necessary for SAC1 redistribution to the ER after mitogen stimulation. However, it remained possible that signaling through the p38 MAPK pathway plays merely a permissive role in this process. To address this question, we expressed dominant active alleles of the upstream kinases MKK3 and 6 (flag-MKK3(Glu) and flag-MKK6(Glu); Raingeaud et al., 1996) in starved COS7 cells. MKK3 and 6 have been shown to specifically activate p38 MAPK without stimulating any of the other MAPKs (Raingeaud et al., 1996). Expression of either flag-MKK3(Glu) or flag-MKK6(Glu) triggered a significant accumulation of SAC1 at the ER in starved cells, thus bypassing the requirement for additional stimulation by serum growth factors (Fig. 4 A).
This result shows that activation of the p38 MAPK pathway is sufficient for triggering SAC1 trafficking.
|
Several studies in yeast and mammalian cells have shown that PI(4)P is enriched at Golgi membranes and promotes Golgi trafficking (Stefan et al., 2002; Godi et al., 2004). Because PI(4)P is the major substrate for SAC1, p38 MAPK-mediated control of SAC1 localization may be a mechanism to regulate PI(4)P-dependent anterograde trafficking out of the Golgi. To examine the role of p38 MAPK in stimulating anterograde trafficking after mitogen stimulation, we analyzed constitutive trafficking out of the Golgi. To this end, we measured the discharge of newly synthesized 35S-labeled proteins into the extracellular medium in pulse-chase experiments. Serum stimulation of quiescent NIH3T3 cells resulted in a substantial increase in secretion compared with mock-treated cells (Fig. 4 D). This increase was significantly attenuated when p38 was inhibited by SB203580 (Fig. 4 D). Moreover, expression of the dominant active flag-MKK3(Glu) stimulated constitutive secretion in serum-starved COS7 cells (Fig. 4 E), further supporting a direct role for p38 in mitogen-dependent regulation of secretion.
Starvation-induced Golgi accumulation of SAC1 down-regulates PI(4)P and slows anterograde traffic
Metabolism of Golgi PIs is regulated by lipid kinases and phosphatases. To determine whether SAC1-mediated turnover of PI(4)P in the Golgi affects anterograde trafficking during starvation, we eliminated SAC1 in starved COS7 cells using RNAi. Depletion of SAC1 with specific siRNAs led to a substantial increase in constitutive secretion in serum-starved cells as compared with the basal secretion level in cells transfected with control siRNAs (Fig. 5 A).
Knockdown of SAC1 in COS7 cells did not affect secretion rates measured after serum stimulation but largely abolished the effect of p38 inhibition on serum-stimulated constitutive secretion (Fig. 5 B). Moreover, RNAi-mediated knockdown of SAC1 in serum-starved COS7 cells led to a stabilization of the Golgi PI(4)P pool (Fig. 5 C). When both siRNAs against SAC1 and a RNAi-resistant phosphatase-dead version of SAC1 (GFP-SAC1-C/S*) were coexpressed in starved cells, Golgi PI(4)P remained prominent and was partially mislocalized to other membranes (Fig. 5 C). In contrast, Golgi PI(4)P was largely reduced when an RNAi-resistant version of wild-type SAC1 (GFP-SAC1*) was coexpressed with siRNAs against SAC1 (Fig. 5 C). Collectively, these results provide direct evidence that both activation of p38 MAPK signaling and SAC1 depletion up-regulate constitutive secretion in starved cells.
|
|
| Discussion |
|---|
|
|
|---|
ERK signaling has also been implicated in cell growth–dependent regulation of Golgi dynamics during mitosis (Acharya et al., 1998; Shaul and Seger, 2006). Basal signaling through the yeast p38 MAPK homologue Hog1p was previously shown to be required for proper localization of a Golgi glycosyl transferase (Reynolds et al., 1998). In addition, stress-induced p38 MAPK signaling was shown to regulate endocytic trafficking (Cavalli et al., 2001). However, a specific function of p38 MAPK in regulating secretion rates has not been previously reported.
Several studies have documented that PI(4)P is highly concentrated at the Golgi and plays an essential role in secretion (for review see De Matteis et al., 2005). PI4 kinases, which generate this PI, are crucial for promoting anterograde trafficking of cargo out of the trans-Golgi network (Wang et al., 2003; Godi et al., 2004). The cellular function of lipid phosphatases that dephosphorylate PI(4)P has been less clear. SAC1 is the major PI(4)P phosphatase in secretory organelles in yeast and mammals (Foti et al., 2001; Schorr et al., 2001; Rohde et al., 2003). One primary function of SAC1 was thought to be in preventing the random dispersion of PI(4)P at intracellular membranes, thus maintaining compartmentalization of PI(4)P pools (Roy and Levine, 2004; Tahirovic et al., 2005). Our results establish a novel growth factor–dependent role for SAC1 that directly links control of Golgi PIs and secretion to cell proliferation (Fig. 7). In the course of serum starvation, SAC1 redistributes to the Golgi and down-regulates the Golgi-specific PI(4)P pool, which in turn lowers the rate of Golgi traffic. SAC1 appears to continuously cycle between the ER and Golgi, and its distribution between these two organelles largely depends on its oligomerization status and on selective recruitment by COP-II or -I complexes. Although our results establish SAC1 as the first enzyme playing a direct role in growth-dependent regulation of Golgi PIs, other components of the lipid signaling machinery may also respond to mitogens. Recent work in yeast has shown that Golgi localization of the PI4 kinase Pik1p is controlled by nutrients and cell proliferation (Faulhammer et al., 2007).
|
| Materials and methods |
|---|
|
|
|---|
(Santa Cruz Biotechnology, Inc.), and sheep polyclonal anti-TGN46 (Serotec). Secondary antibodies conjugated either with HRP, TRITC, or FITC were obtained from Jackson ImmunoResearch Laboratories. Basic FGF, PDGF-AB, and mouse EGF were purchased from PeproTech. The MEK1/2 inhibitor UO126 and p38 MAPK inhibitor SB203580 were purchased from InvivoGen. The JNK inhibitor SP600125 was purchased from BIOMOL International, L.P. Rapamycin and wortmannin were purchased from EMD. Phosphatase inhibitor cocktail 1 was purchased from Sigma-Aldrich and Complete Mini EDTA-free protease inhibitor cocktail was purchased from Roche. [35S]-EXPRESS Easy Tag protein labeling mix, [32P]orthophosphate, and [3H]myo-inositol were purchased from PerkinElmer. All cell culture media were purchased from Thermo Fisher Scientific, FCS was purchased from Hyclone, and newborn bovine serum (NBS) was purchased from Sigma-Aldrich.
DNA constructs and recombinant adenoviruses
The plasmids for expressing flag-MKK3(Glu) and flag-MKK6(Glu) were a gift from R. Davis (University of Massachussetts Medical School, Worcester, MA). The plasmids for expressing CD4-GFP-KKYL and CD4-GFP-AAYL chimeras were obtained from B. Schwappach (University of Manchester, Manchester, UK). cDNAs encoding flag- and GFP-tagged human SAC1 and SAC1-K2A were generated as previously described (Rohde et al., 2003). The cDNA encoding SAC1-LZ containing four leucine-to-alanine substitutions (L105A, L112A, L119A, and L126A) was generated by site-directed mutagenesis using the primers sac1-1 (5'-GACAATGGCGCACTTAACTGATATTCAGGCACAAGATA-3'), sac1-2 (5'-TATCTTGTGCCTGAATATCAGTTAAGTGCGCCATTGTC-3'), sac1-3 (5'-CCTTCGCAGCGATGCTAAACCATGTCGCGAATGTGGA-3'), and sac1-4 (5'-TCCACATTCGCGACATGGTTTAGCATCGCTGCGAAGG-3'). The cDNA encoding GFP-SAC1
N was constructed by PCR using primers sac1-5 (5'-TGCAGATCTTAAGTGTTCCAAGGGACTGG-3') and sac1-6 (5'-GGACTGCAGTCAGTCTATCTTTTCTTTCTGG-3'). The adenovirus system was obtained from K. Früh (Oregon Health and Science University). Recombinant adenoviruses expressing GFP-tagged SAC1, SAC1-K2A, and SAC1-LZ were produced as previously described (Hitt et al., 1997).
Cell lines, mitogen stimulation, transfections, and infections
Monkey kidney COS7 cells were grown as previously described (Rohde et al., 2003). Mouse embryonic fibroblast NIH3T3 cells (CRL-1658; American Type Culture Collection) and primary human fibroblasts (GM00442; Coriell Cell Repositories) were cultured according to the manufacturer's instructions. All cells were grown at 37°C in a humidified atmosphere of 5% CO2. To generate a quiescent cell population, cells were plated and cultured using reduced serum concentrations (0.3–0.5%) for 24–48 h. Stimulation of quiescent cells was performed with either 10 or 15% calf serum or with growth factors (5 ng/ml basic FGF, 3 ng/ml PDGF-AB, or 5 ng/ml EGF). Cells were transfected by electroporation essentially as previously described (Norcott et al., 1996) or infected with transactivator (MOI = 5) and recombinant adenoviruses for 24 (MOI = 10) or 48 h (MOI = 3).
Immunofluorescence microscopy and image analysis
Immunofluorescent staining was performed using paraformaldehyde-fixed and saponin-permeabilized cells as previously described (Blagoveshchenskaya et al., 2002). The mounting medium used was Prolong Antifade (Invitrogen). The fluorochromes were FITC, TRITC, and Alexa Fluor 350. Samples were viewed at 25°C using a microscope (Eclipse E800; Nikon) equipped with a camera (CoolSNAP HQ; Photometrics) and a 60x oil objective (1.45 NA). Confocal micrographs were obtained using a microscope (BX51; Olympus) and a 60x oil objective (1.45 NA; Plan Apo; Olympus). Image acquisition was performed using Metamorph Image software (7.0; MDS Analytical Technologies). Images were analyzed using Image J software (National Institutes of Health) and Photoshop CS (version 8.0; Adobe).
Quantification of the time course of SAC1 trafficking
Images of endogenous SAC1 immunofluorescence were captured at 25°C using a spinning disk confocal microscope (Eclipse TE2000-E; Nikon) equipped with a camera (Orca-ER; Hamamatsu) and a 60x oil objective (1.45 NA; Plan Apo). Image acquisition was performed using QED InVivo (Media Cybernetics, Inc.). All image processing was done with Metamorph software. Because the ER and Golgi occupy different z planes of the cell, images for quantification were made by condensing individual z series (15 planes, 0.5 µm apart) to a single plane by maximum intensity projection. The ratio of mean Golgi to ER fluorescence was used as a measure of SAC1 accumulation in the Golgi. Before analysis, the mean background from areas of the coverslip devoid of cells was subtracted from each image. For each cell, the fluorescence intensity along a 10-pixel-wide line that intersected both the ER and Golgi was used to measure the mean fluorescence intensity in both the Golgi and ER regions (using the linescan function in Metamorph). The boundaries of the Golgi and ER were determined morphologically from the SAC1 signal. The Golgi to ER ratios for each construct were calculated from a minimum of seven cells at each time point.
RNAi
Cells were transfected with 0.2 µM siRNA directed against SAC1 (5'-GGCGUGUUCCGAAGCAAUU-3') using Lipofectamine 2000 (Invitrogen). Control siRNAs were generated by changing three nucleotides in the siRNA sequence (5'-AGCGUGGUCCGAAGCCAUU-3'). To express RNAi-resistant SAC1 proteins, five silent mutations were introduced into the region of recombinant SAC1 that is targeted by siRNAs. Transfected cells were assayed 72 h after transfection.
PI analysis
After 24 h of labeling with 10 µCi/ml [3H]myo-inositol in inositol-free MEM (ICN) supplemented with 10% dialyzed NBS, cells were washed with ice-cold PBS. Subsequently, 1 ml of ice-cold 0.5-M perchloric acid was added and the cells were scraped into an eppendorf tube. The resulting pellet was washed once with ice-cold 0.5-M perchloric acid. To solubilize lipids, 750 µl methanol/chloroform/HCl (80:40:1 vol/vol) was added to the pellet and mixed briefly. After incubation at room temperature for 30 min, 250 µl chloroform and 450 µl of 0.1-M HCl were added. After 1 min of centrifugation, the lower organic phase was transferred to a new tube and the upper aqueous phase was neutralized with 50 µl of 1-M NH4OH/methanol. The aqueous phase was reextracted twice with 225 µl methanol/chloroform/HCl (80:40:1 vol/vol), 75 µl chloroform, and 135 µl of 0.1-M HCl. The pooled organic phases were washed with 5 vol of 2-M KCl and dried in a SpeedVac (Savant Instruments).
Dried lipid pellet was deacylated by adding 200 µl methlyamine reagent and incubated in a sealed tube at 53°C for 30 min. The mixture was dried in a SpeedVac and the dried lipid pellet was redissolved in 500 µl of distilled water and 600 µl 1-butanol/petroleum ether/ethyl formate (H2O-saturated; 20:4:1 vol/vol), vortexed, and centrifuged for 1 min. The upper phase was discarded and this step was repeated once more with the lower phase, followed by final extraction with petroleum ether/ethyl formate (4:1, vol/vol). The lower phase was dried in a SpeedVac and the pellet was resuspended with 160 µl of 10-mM (NH4)4HPO4, pH 3.8.
HPLC analysis of glycerophosphoinositols was performed on a HPLC system (Jasco) equipped with an LB 508 Radioflow detector (Berthold Technologies). The following gradient for elution of the HPLC column was used: buffer A (distilled water) and buffer B (1 M (NH4)4HPO4, pH 3.8). The gradient was run at 0% buffer B for 10 min and increased to 25% buffer B over 60 min and then 20 min at 0% buffer B. The flow rate was 1 ml/min. Data from at least four independent experiments were used to calculate the respective mean values. To test for the statistical significance of difference between two percentages, t test analysis was performed.
Phosphatase assay
COS7 cells were infected with adenoviruses to express flag-tagged versions of SAC1, SAC1-LZ, or phosphatase-dead SAC1-C/S (Rohde et al., 2003). 2 d after infection, the cells were washed once with PBS and harvested in modified RIPA buffer (1% NP-40, 1% sodium deoxycholate, 150 mM NaCl, 50 mM Tris-HCl, and protease inhibitors, pH 8.0). After centrifugation at 13,000 g for 15 min, flag-tagged SAC1 proteins were collected on M2 agarose beads. The SAC1 proteins were eluted from the beads with 200 µg/ml M2 peptide in TBS for 2 h at 4°C. For measuring phosphatase activity, a modified version of a published protocol was used (Maehama et al., 2000). 24 µl of reaction buffer (200 mM sodium acetate, 100 mM Bis-Tris, 100 mM Tris, pH 6.0, 0.002% porcine gelatin, and 4 mM DTT), 1.4 µl of 1-M dioctanoyl-PI(4)P in water (Sigma-Aldrich) and 25 µl of eluate containing 2 µg of recombinant SAC1 protein was mixed and incubated at 37°C for various times. Reactions were stopped by the addition of an equal amount of 100 mM NEM, and 25 µl of each supernatant was pipetted into 96-well plates. 50 µl of Malachite green solution (1 vol of 4.2% ammonium molybdate in 4 M HCl and 3 vol of 0.045% Malachite green and 0.01% Tween 20) was added to each well. After incubation for 20 min at room temperature the OD620 was measured.
Secretion assay
NIH3T3 or COS7 cells were starved in DME supplemented with 0.5% serum or without serum, respectively, for 24 h to induce quiescence. Cells were either pretreated with 10 µM SB203580 or mock treated and then stimulated or not with 10% serum. Subsequently, cells were labeled with [35S]-EXPRESS for 15 min at 37°C. The cells were then washed and chased for various times at 37°C in the corresponding unlabeled DME. To determine the kinetics of secretion, the incubation medium was collected at different times and cells were lysed in modified RIPA buffer. 35S-labeled proteins were precipitated with 3% TCA from both media and lysates, collected on filters (GF/C; Whatman), and quantified by scintillation counting. For controls, cells were left on ice before supernatants were collected and analyzed.
Immunoprecipitation
COS7 cells were electroporated with 5 µg cDNAs encoding for SAC1 mutants. 2 d after transfection, the cells were washed once with PBS and harvested in colitose (coIP) buffer (PBS, pH 7.5, 1% NP-40, and protease inhibitor cocktail). After centrifugation at 13,000 g for 15 min at 4°C, the supernatants were precleared with agarose beads for 1 h at 4°C. The resulting supernatants were incubated with M2 agarose for 2 h at 4°C. The beads were collected by centrifugation and washed once with ice-cold coIP buffer, twice with coIP buffer containing 0.5 M NaCl, and once with PBS. The proteins were eluted in Laemmli buffer and analyzed by immunoblotting.
Online supplemental material.
Fig. S1 shows that SAC1 shuttling is not sensitive to cycloheximide. This figure also displays shuttling defects of an N-terminally truncated GFP-SAC1 mutant. Fig. S2 shows that Golgi-to-ER shuttling of SAC1 is not inhibited by wortmannin and rapamycin. This figure also shows that inhibition of p38 does not block general Golgi-to-ER traffic. Fig. S3 shows that MAPK inhibition does not affect steady-state distribution of SAC1 or Golgi morphology in proliferating cells. Online supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.200708109/DC1.
| Acknowledgments |
|---|
This research was supported by a grant from the National Institutes of Health/National Institute of General Medical Sciences to P. Mayinger (GM071569).
Submitted: 15 August 2007
Accepted: 29 January 2008
| References |
|---|
|
|
|---|
Acharya, U., A. Mallabiabarrena, J.K. Acharya, and V. Malhotra. 1998. Signaling via mitogen-activated protein-kinase kinase (MEK 1) is required for Golgi fragmentation during mitosis. Cell. 92:183–192.[CrossRef][Medline]
Blagosklonny, M.V. 2006. Target for cancer therapy: proliferating cells or stem cells. Leukemia. 20:385–391.[CrossRef][Medline]
Blagoveshchenskaya, A.D., M.J. Hannah, S. Allen, and D.F. Cutler. 2002. Selective and signal-dependent recruitment of membrane proteins to secretory granules formed by heterologously expressed von Willebrand factor. Mol. Biol. Cell. 13:1582–1593.
Cavalli, V., F. Vilbois, M. Corti, M.J. Marcote, K. Tamura, M. Karin, S. Arkinstall, and J. Gruenberg. 2001. The stress-induced MAP kinase p38 regulates endocytic trafficking via the GDI:Rab5 complex. Mol. Cell. 7:421–432.[CrossRef][Medline]
De Matteis, M.A., A. Di Campli, and A. Godi. 2005. The role of the phosphoinositides at the Golgi complex. Biochim. Biophys. Acta. 1744:396–405.[Medline]
Di Paolo, G., and P. De Camilli. 2006. Phosphoinositides in cell regulation and membrane dynamics. Nature. 443:651–657.[CrossRef][Medline]
English, J.M., and M.H. Cobb. 2002. Pharmacological inhibitors of MAPK pathways. Trends Pharmacol. Sci. 23:40–45.[CrossRef][Medline]
Faulhammer, F., G. Konrad, B. Brankatschk, S. Tahirovic, A. Knodler, and P. Mayinger. 2005. Cell growth–dependent coordination of lipid signaling and glycosylation is mediated by interactions between Sac1p and Dpm1p. J. Cell Biol. 168:185–191.
Faulhammer, F., S. Kanjilal-Kolar, A. Knodler, J. Lo, Y. Lee, G. Konrad, and P. Mayinger. 2007. Growth control of Golgi phosphoinositides by reciprocal localization of sac1 lipid phosphatase and pik1 4-kinase. Traffic. 8:1554–1567.[CrossRef][Medline]
Foti, M., A. Audhya, and S.D. Emr. 2001. Sac1 lipid phosphatase and stt4 phosphatidylinositol 4-kinase regulate a pool of phosphatidylinositol 4-phosphate that functions in the control of the actin cytoskeleton and vacuole morphology. Mol. Biol. Cell. 12:2396–2411.
Godi, A., P. Pertile, R. Meyers, P. Marra, G. Di Tullio, C. Iurisci, A. Luini, D. Corda, and M.A. De Matteis. 1999. ARF mediates recruitment of PtdIns-4-OH kinase-beta and stimulates synthesis of PtdIns(4,5)P2 on the Golgi complex. Nat. Cell Biol. 1:280–287.[CrossRef][Medline]
Godi, A., A.D. Campli, A. Konstantakopoulos, G.D. Tullio, D.R. Alessi, G.S. Kular, T. Daniele, P. Marra, J.M. Lucocq, and M.A. Matteis. 2004. FAPPs control Golgi-to-cell-surface membrane traffic by binding to ARF and PtdIns(4)P. Nat. Cell Biol. 6:393–404.[CrossRef][Medline]
Hedin, U., J. Roy, and P.K. Tran. 2004. Control of smooth muscle cell proliferation in vascular disease. Curr. Opin. Lipidol. 15:559–565.[CrossRef][Medline]
Hitt, M.M., C.L. Addison, and F.L. Graham. 1997. Human adenovirus vectors for gene transfer into mammalian cells. Adv. Pharmacol. 40:137–206.[Medline]
Johnson, G.L., and R. Lapadat. 2002. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 298:1911–1912.
Larsson, O., A. Zetterberg, and W. Engstrom. 1985. Cell-cycle-specific induction of quiescence achieved by limited inhibition of protein synthesis: counteractive effect of addition of purified growth factors. J. Cell Sci. 73:375–387.[Abstract]
Letourneur, F., S. Hennecke, C. Demolliere, and P. Cosson. 1995. Steric masking of a dilysine endoplasmic reticulum retention motif during assembly of the human high affinity receptor for immunoglobulin E. J. Cell Biol. 129:971–978.
Lupas, A. 1996. Coiled coils: new structures and new functions. Trends Biochem. Sci. 21:375–382.[CrossRef][Medline]
Maehama, T., G.S. Taylor, J.T. Slama, and J.E. Dixon. 2000. A sensitive assay for phosphoinositide phosphatases. Anal. Biochem. 279:248–250.[CrossRef][Medline]
Norcott, J.P., R. Solari, and D.F. Cutler. 1996. Targeting of P-selectin to two regulated secretory organelles in PC12 cells. J. Cell Biol. 134:1229–1240.
Raingeaud, J., A.J. Whitmarsh, T. Barrett, B. Derijard, and R.J. Davis. 1996. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell. Biol. 16:1247–1255.[Abstract]
Reynolds, T.B., B.D. Hopkins, M.R. Lyons, and T.R. Graham. 1998. The high osmolarity glycerol response (HOG) MAP kinase pathway controls localization of a yeast golgi glycosyltransferase. J. Cell Biol. 143:935–946.
Rohde, H.M., F.Y. Cheong, G. Konrad, K. Paiha, P. Mayinger, and G. Boehmelt. 2003. The human phosphatidylinositol phosphatase SAC1 interacts with the coatomer I complex. J. Biol. Chem. 278:52689–52699.
Roy, A., and T.P. Levine. 2004. Multiple pools of phosphatidylinositol 4-phosphate detected using the pleckstrin homology domain of Osh2p. J. Biol. Chem. 279:44683–44689.
Schorr, M., A. Then, S. Tahirovic, N. Hug, and P. Mayinger. 2001. The phosphoinositide phosphatase Sac1p controls trafficking of the yeast Chs3p chitin synthase. Curr. Biol. 11:1421–1426.[CrossRef][Medline]
Shaul, Y.D., and R. Seger. 2006. ERK1c regulates Golgi fragmentation during mitosis. J. Cell Biol. 172:885–897.
Stefan, C.J., A. Audhya, and S.D. Emr. 2002. The yeast synaptojanin-like proteins control the cellular distribution of phosphatidylinositol (4,5)-bisphosphate. Mol. Biol. Cell. 13:542–557.
Tahirovic, S., M. Schorr, and P. Mayinger. 2005. Regulation of intracellular phosphatidylinositol-4-phosphate by the Sac1 lipid phosphatase. Traffic. 6:116–130.[CrossRef][Medline]
Vanhaesebroeck, B., K. Ali, A. Bilancio, B. Geering, and L.C. Foukas. 2005. Signalling by PI3K isoforms: insights from gene-targeted mice. Trends Biochem. Sci. 30:194–204.[CrossRef][Medline]
Walch-Solimena, C., and P. Novick. 1999. The yeast phosphatidylinositol-4-OH kinase pik1 regulates secretion at the Golgi. Nat. Cell Biol. 1:523–525.[CrossRef][Medline]
Wang, Y.J., J. Wang, H.Q. Sun, M. Martinez, Y.X. Sun, E. Macia, T. Kirchhausen, J.P. Albanesi, M.G. Roth, and H.L. Yin. 2003. Phosphatidylinositol 4 phosphate regulates targeting of clathrin adaptor AP-1 complexes to the Golgi. Cell. 114:299–310.[CrossRef][Medline]
Weixel, K.M., A. Blumental-Perry, S.C. Watkins, M. Aridor, and O.A. Weisz. 2005. Distinct Golgi populations of phosphatidylinositol 4-phosphate regulated by phosphatidylinositol 4-kinases. J. Biol. Chem. 280:10501–10508.
Wymann, M.P., and R. Marone. 2005. Phosphoinositide 3-kinase in disease: timing, location, and scaffolding. Curr. Opin. Cell Biol. 17:141–149.[CrossRef][Medline]
Zeisberg, M., F. Strutz, and G.A. Muller. 2000. Role of fibroblast activation in inducing interstitial fibrosis. J. Nephrol. 13:S111–S120.[CrossRef][Medline]
Zerangue, N., M.J. Malan, S.R. Fried, P.F. Dazin, Y.N. Jan, L.Y. Jan, and B. Schwappach. 2001. Analysis of endoplasmic reticulum trafficking signals by combinatorial screening in mammalian cells. Proc. Natl. Acad. Sci. USA. 98:2431–2436.
Related In this Issue article
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|